Acute and maintenance treatment with mood stabilizers

Area of Science:

• Psychiatry and Neuroscience
• Pharmacology
• Clinical Therapeutics

Background:

• Bipolar disorder presents complex challenges including multiple illness phases, variable symptomatology, and limited efficacy of current mood stabilizers.
• While placebo-controlled trials offer clear efficacy data for mania, evidence for secondary treatment questions, like augmenting lithium or valproate, is often limited and from less robust studies.
• Valproate demonstrates a broader efficacy spectrum for mania compared to other mood stabilizers, yet many patients do not achieve adequate benefit from monotherapy.

Purpose of the Study:

• To review the current evidence for mood stabilizer efficacy in bipolar disorder, focusing on mania and maintenance treatment.
• To evaluate the effectiveness of combination therapies and specific agents like lamotrigine in managing different phases of bipolar disorder.
• To identify gaps in treatment guidelines, particularly for special populations such as youth, pregnant women, and the elderly.

Main Methods:

• Review of randomized, blinded, placebo-controlled studies and other relevant clinical trials on mood stabilizers for bipolar disorder.
• Analysis of evidence regarding monotherapy versus combination therapy for acute mania.
• Examination of maintenance treatment data for lithium, valproate, and lamotrigine, including their effects on manic and depressive relapse.

Main Results:

• Combination therapy with an antipsychotic and a mood stabilizer is more effective for mania than continuing mood stabilizer monotherapy.
• Lithium and valproate are effective for preventing manic relapse and controlling manic symptoms, but may worsen depressive symptoms in some cases.
• Lamotrigine is effective in delaying relapse, primarily into depressive episodes, and does not induce mania or rapid cycling, unlike traditional antidepressants.

Conclusions:

• Mood stabilizers have varying efficacy and limitations across bipolar disorder phases; combination therapy offers improved outcomes for acute mania.
• Lithium, valproate, and lamotrigine are effective for maintenance, with distinct benefits for manic versus depressive relapse prevention.
• Further systematic research is crucial to establish clear treatment guidelines for specific populations, including adolescents and the elderly.